who can use semaglutide Semaglutide: Diabetes Care & Weight Management Semaglutide: Weight Loss and Diabetes

This general guidance remains applicable for patients taking GLP-1 medications

Wegovy (semaglutide) It was the first weekly injectable GLP-1 approved specifically for weight management in adults with a body mass index of 30 or higher, or 27 and above with at least one weight-related condition such as high blood pressure or type 2 diabetes

Embrace optimization today for a future of improved aging

The court in Beijing backed the validity of Novo Nordisk's compound patent for semaglutide, which is the main ingredient in the company's obesity therapy Wegovy and diabetes treatments Ozempic and Rybelsus, used by tens of millions of people worldwide